Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function
Related Experiment Video
Updated: Apr 24, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Qijun Li1, Changzheng Dong2, Wenling Li2
1Graduate School, Hebei Medical University, Shijiazhuang, Hebei Province, China.
Abstract:
Neuropeptide Y has been shown to inhibit the immunological activity of reactive microglia in the rat cerebral cortex, to reduce N-methyl-D-aspartate current (I NMDA) in cortical neurons, and protect neurons. In this study, after primary cultured microglia from the cerebral cortex of rats were treated with lipopolysaccharide, interleukin-1β and tumor necrosis factor-α levels in the cell culture medium increased, and mRNA expression of these cytokines also increased. After primary cultured cortical neurons were incubated with the lipopolysaccharide-treated microglial conditioned medium, peak I NMDA in neurons increased. These effects of lipopolysaccharide were suppressed by neuropeptide Y. After addition of the neuropeptide Y Y1 receptor antagonist BIBP3226, the effects of neuropeptide Y completely disappeared. These results suggest that neuropeptide Y prevents excessive production of interleukin-1β and tumor necrosis factor-α by inhibiting microglial reactivity. This reduces I NMDA in rat cortical neurons, preventing excitotoxicity, thereby protecting neurons.
Insights
Neuropeptide Y protects rat cortical neurons from excitotoxicity by inhibiting reactive microglia and reducing harmful N-methyl-D-aspartate current. This neuroprotective effect is mediated via the Neuropeptide Y Y1 receptor.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Reactive microglia contribute to neuroinflammation and excitotoxicity.
- Neuropeptide Y (NPY) exhibits neuroprotective properties.
- Microglial activation elevates pro-inflammatory cytokines and N-methyl-D-aspartate (NMDA) currents.
Purpose of the Study:
- To investigate the role of Neuropeptide Y in modulating microglial activation and its downstream effects on cortical neurons.
- To elucidate the involvement of the Neuropeptide Y Y1 receptor in these neuroprotective mechanisms.
Main Methods:
- Primary rat cortical microglia were treated with lipopolysaccharide (LPS).
- Cytokine levels (interleukin-1β, tumor necrosis factor-α) and mRNA expression were measured.
- Primary rat cortical neurons were exposed to conditioned medium from LPS-treated microglia.
- N-methyl-D-aspartate current (I NMDA) in neurons was recorded.
- The effects of Neuropeptide Y and its Y1 receptor antagonist (BIBP3226) were assessed.
Main Results:
- LPS treatment increased interleukin-1β and tumor necrosis factor-α in microglia.
- LPS-induced microglial conditioned medium enhanced neuronal I NMDA.
- Neuropeptide Y suppressed LPS-induced cytokine production and normalized neuronal I NMDA.
- The Neuropeptide Y Y1 receptor antagonist BIBP3226 abolished the effects of Neuropeptide Y.
Conclusions:
- Neuropeptide Y inhibits microglial reactivity, reducing pro-inflammatory cytokine release.
- Neuropeptide Y protects cortical neurons from excitotoxicity by decreasing I NMDA.
- The Neuropeptide Y Y1 receptor mediates these neuroprotective effects against inflammation-induced neuronal damage.
More Related Videos
Related Concept Videos
Glial Cells
Nervous Tissue: Glial Cells
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
Neurogenesis and Regeneration of Nervous Tissue
The Blood-brain Barrier

